ES2062310T3
(es)
|
1989-12-06 |
1994-12-16 |
Akzo Nv |
Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado.
|
EP0813873B1
(en)
|
1996-06-19 |
2002-02-13 |
Akzo Nobel N.V. |
Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
|
EP1011656A2
(en)
|
1996-11-05 |
2000-06-28 |
Head Explorer ApS |
A method for treating tension-type headache
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
BR9815098A
(pt)
|
1997-11-14 |
2000-10-10 |
Akzo Nobel Nv |
Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
|
CA2321900C
(en)
|
1998-02-27 |
2011-07-19 |
The Board Of Trustees Of The University Of Illinois |
Agents with serotonin-related activity for the treatment for sleep apnea
|
EP1067934B1
(en)
|
1998-04-02 |
2003-11-26 |
Akzo Nobel N.V. |
Oral liquid solution comprising the antidepressant mirtazapine
|
US6211171B1
(en)
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
AU781221B2
(en)
|
1999-04-19 |
2005-05-12 |
Teva Pharmaceutical Industries Ltd. |
Novel synthesis and crystallization of piperazine ring-containing compounds
|
PL351395A1
(en)
|
1999-04-19 |
2003-04-07 |
Teva Pharma |
Novel synthesis of piperazine ring
|
US6245782B1
(en)
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
EP1185263A2
(en)
|
1999-06-15 |
2002-03-13 |
Respiratorius AB |
Receptor agonists and antagonists
|
US6281207B1
(en)
|
1999-09-15 |
2001-08-28 |
Reed Richter |
Treatment of movement disorders by administration of mirtazapine
|
TWI256309B
(en)
|
1999-10-13 |
2006-06-11 |
Akzo Nobel Nv |
New formulation of mirtazapine
|
WO2001038329A1
(fr)
|
1999-11-24 |
2001-05-31 |
Sumika Fine Chemicals Co., Ltd. |
Cristaux de mirtazapine anhydre et leur procede d'obtention
|
AU6474200A
(en)
|
1999-12-13 |
2001-06-18 |
Sumika Fine Chemicals Co., Ltd. |
Process for the preparation of a pyridinemethanol compound
|
US20050074487A1
(en)
*
|
1999-12-16 |
2005-04-07 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
CA2396209C
(en)
|
2000-02-11 |
2009-09-01 |
Akzo Nobel N.V. |
The use of mirtazapine for the treatment of sleep disorders
|
US7678387B2
(en)
|
2000-06-06 |
2010-03-16 |
Capricorn Pharma, Inc. |
Drug delivery systems
|
US6375982B1
(en)
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
US20020072602A1
(en)
|
2000-07-07 |
2002-06-13 |
Claude Singer |
Micronized mirtazapine
|
US7074961B2
(en)
|
2000-09-26 |
2006-07-11 |
The Brigham And Women's Hospital, Inc. |
Antidepressants and their analogues as long-acting local anesthetics and analgesics
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
US6660730B2
(en)
|
2000-11-27 |
2003-12-09 |
Sumika Fine Chemicals Co., Ltd. |
Anhydrous mirtazapine and process for preparing the same
|
WO2002064735A2
(en)
|
2001-02-12 |
2002-08-22 |
Akzo Nobel N.V. |
Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
|
WO2002070513A1
(en)
|
2001-03-01 |
2002-09-12 |
Teva Pharmaceutical Industries Ltd. |
Methods for the preparation of mirtazapine intermediates
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
ITMI20011446A1
(it)
|
2001-07-06 |
2003-01-06 |
Altergon Sa |
Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
|
WO2007064311A1
(en)
|
2001-07-10 |
2007-06-07 |
Teva Pharmaceutical Industries Ltd. |
Micronized mirtazapine
|
DE10153078A1
(de)
|
2001-10-30 |
2003-05-22 |
Degussa |
Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
|
EP1941878A1
(en)
|
2002-01-10 |
2008-07-09 |
Biovail Laboratories International Srl |
Sedative non-benzodiazepine formulations
|
WO2003075851A2
(en)
|
2002-03-06 |
2003-09-18 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
US20030194420A1
(en)
|
2002-04-11 |
2003-10-16 |
Richard Holl |
Process for loading a drug delivery device
|
FR2842734A1
(fr)
|
2002-07-24 |
2004-01-30 |
Ethypharm Sa |
Procede pour diminuer la variabilite de la biodisponibilite d'un medicament a administration orale et compositions pharmaceutiques a administration orale
|
US20120156144A1
(en)
|
2002-10-25 |
2012-06-21 |
Foamix |
Foamable Compositions, Kits and Methods for Hyperhidrosis
|
EP1562557B2
(en)
|
2002-11-01 |
2016-11-16 |
University of Medicine and Dentistry of New Jersey |
Geodate delivery vehicles
|
US20050013845A1
(en)
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
WO2004084905A2
(en)
|
2003-03-24 |
2004-10-07 |
University Of Florida |
Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
|
JP4739217B2
(ja)
|
2003-05-07 |
2011-08-03 |
サムヤン コーポレイション |
速く溶ける錠剤を製造するための高可塑性顆粒
|
US7041826B2
(en)
|
2003-06-02 |
2006-05-09 |
Aurobindo Pharma Ltd. |
Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate
|
UA83666C2
(ru)
|
2003-07-10 |
2008-08-11 |
Н.В. Органон |
Способ получения энантиомерно чистого миртазапина
|
AU2003903597A0
(en)
|
2003-07-11 |
2003-07-24 |
Jakov Vaisman |
Treatment of premature ejaculation
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
US7838029B1
(en)
|
2003-07-31 |
2010-11-23 |
Watson Laboratories, Inc. |
Mirtazapine solid dosage forms
|
MXPA06001776A
(es)
|
2003-08-15 |
2007-09-07 |
Qlt Usa Inc |
Sistema de suministro de farmaco transmucosal biocorrosivo, adhesivo.
|
CN1863517B
(zh)
|
2003-10-07 |
2011-08-03 |
安壮奇制药公司 |
快速崩解制剂
|
EP1689371A2
(en)
|
2003-11-25 |
2006-08-16 |
Aurobindo Pharma Limited |
Pharmaceutical compositions of mirtazapine
|
WO2005063213A1
(en)
|
2003-12-19 |
2005-07-14 |
Biodelivery Sciences International, Inc. |
Rigid liposomal cochleate and methods of use and manufacture
|
US7713959B2
(en)
|
2004-01-13 |
2010-05-11 |
Duke University |
Compositions of an anticonvulsant and mirtazapine to prevent weight gain
|
WO2005089511A2
(en)
|
2004-03-19 |
2005-09-29 |
Transform Pharmaceuticals, Inc. |
Novel pharmaceutical forms, and methods of making and using the same
|
TW200538100A
(en)
|
2004-04-21 |
2005-12-01 |
Akzo Nobel Nv |
Mirtazapine salts
|
DE102004034043A1
(de)
|
2004-07-13 |
2006-02-09 |
Krka Tovarna Zdravil, D.D. |
Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
|
ES2246161B1
(es)
|
2004-07-22 |
2007-04-01 |
Medichem, S.A. |
Proceso mejorado para la fabricacion de mirtazapina.
|
WO2006017861A2
(en)
|
2004-08-13 |
2006-02-16 |
Omeros Corporation |
Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists
|
US20060127479A1
(en)
|
2004-10-08 |
2006-06-15 |
Natrajan Kumaraperumal |
Solvent free taste masked pharmaceutical compositions
|
TW200631584A
(en)
|
2004-11-15 |
2006-09-16 |
Akzo Nobel Nv |
A medicament related to mirtazapine for the treatment of hot flush
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8512751B2
(en)
|
2004-12-20 |
2013-08-20 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical compositions for sleep disorders
|
WO2006088305A1
(en)
|
2005-02-15 |
2006-08-24 |
Chong Kun Dang Pharmaceutical Corp. |
Gastric-retentive controlled release mono-matrix tablet
|
US20090075974A1
(en)
|
2005-04-27 |
2009-03-19 |
Umn Pharma Inc. |
Agent for prophylaxis and treatment of pancreatitis
|
US20090306046A1
(en)
|
2005-06-27 |
2009-12-10 |
N.V. Organon |
Method of treatment of hormone depletion induced vasomotor symptoms
|
US20080200533A1
(en)
|
2005-07-04 |
2008-08-21 |
Ramu Krishnan |
Drug or Pharmaceutical Compounds and a Preparation Thereof
|
WO2007012154A1
(en)
|
2005-07-27 |
2007-02-01 |
Carlos Henrique Horta Lima |
Pharmaceutical preparation containing an acetylcholinesterase ihibitor and an antidepressant with 5-ht and alpha-2-adrenoceptor blocking properties.
|
WO2007019880A1
(en)
|
2005-08-18 |
2007-02-22 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Use of a selective inhibitor of norepinephrine reuptake for treating respiratory disorders resulting from rett syndrome
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
CN102153620A
(zh)
|
2005-09-26 |
2011-08-17 |
住友化学株式会社 |
光学活性的哌嗪化合物的制造方法
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
EP1948248A2
(en)
|
2005-11-06 |
2008-07-30 |
Katz-Brull, Rachel |
Magnetic resonance imaging and spectroscopy means and methods thereof
|
WO2007057508A2
(en)
|
2005-11-18 |
2007-05-24 |
Orion Corporation |
Treatment of pain with a combination of an alpha2 -adrenoceptor antagonist such as atipemezole or fipamezoiie and an opioid receptor agonist, such as tramadol
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
EP3132792B1
(en)
|
2005-11-22 |
2019-09-11 |
Nalpropion Pharmaceuticals, Inc. |
Composition and methods for increasing insulin sensitivity
|
EP1792618A1
(en)
|
2005-11-30 |
2007-06-06 |
Rainer Freynhagen |
R-mirtazapine for the treatment of pain
|
US7541371B2
(en)
|
2006-02-20 |
2009-06-02 |
Eisai R&D Management Co., Ltd. |
Method for treating a motor neuron disease
|
EP1993556A1
(en)
|
2006-03-06 |
2008-11-26 |
N.V. Organon |
An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
|
FR2900339B1
(fr)
|
2006-04-28 |
2008-07-25 |
Univ Claude Bernard Lyon I Eta |
Utilisation d'un compose qui induit une augmentation du taux de serotonine libre dans l'organisme, pour la preparation d'un medicament destine a traiter des degenerescences du muscle squelettique
|
TW200808804A
(en)
|
2006-05-22 |
2008-02-16 |
Organon Nv |
Mirtazapine for the treatment of neuropathic pain
|
US20070270413A1
(en)
|
2006-05-22 |
2007-11-22 |
N.V. Organon |
Mirtazapine for the treatment of neuropathic pain
|
WO2007146331A1
(en)
|
2006-06-12 |
2007-12-21 |
Teva Pharmaceutical Industries, Ltd. |
Tannate salt form of polypeptide mixtures, their preparation and use
|
DE102006027792A1
(de)
|
2006-06-16 |
2007-12-20 |
Lts Lohmann Therapie-Systeme Ag |
Antidepressiva-Kombinations-Wafer
|
US20080014252A1
(en)
|
2006-07-14 |
2008-01-17 |
Delprete Keith |
Topical compositions with long lasting effect
|
WO2008060397A2
(en)
|
2006-11-03 |
2008-05-22 |
Noven Therapeutics, Llc |
Method of treating thermoregulatory disfunction
|
MX2009005446A
(es)
|
2006-11-22 |
2009-06-02 |
Organon Nv |
Sistema de suministro vaginal para mirtazapina.
|
WO2008104996A2
(en)
|
2007-02-28 |
2008-09-04 |
Jubilant Organosys Limited |
Water dispersible pharmaceutical formulation and process for preparing the same
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
JP5192707B2
(ja)
|
2007-03-22 |
2013-05-08 |
住友化学株式会社 |
ミルタザピンの製造方法
|
US20080255348A1
(en)
|
2007-04-11 |
2008-10-16 |
N.V. Organon |
Method for the preparation of an enantiomer of a tetracyclic benzazepine
|
JP5635905B2
(ja)
|
2007-04-11 |
2014-12-03 |
メルク・シャープ・エンド・ドーム・ベー・フェー |
ミルタザピンの調製方法
|
US7994314B2
(en)
|
2007-04-11 |
2011-08-09 |
N.V. Organon |
Method for the preparation of an enantiomerically pure benzazepine
|
EP2133350B1
(en)
|
2007-04-11 |
2016-03-23 |
Merck Sharp & Dohme B.V. |
A method for the preparation of an enantiomerically pure benzazepine
|
WO2009018088A2
(en)
|
2007-08-01 |
2009-02-05 |
Link Medicine Corporation |
Imaging of alpha-synuclein
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
EA019760B1
(ru)
*
|
2007-11-02 |
2014-06-30 |
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи |
Система трансдермальной доставки, способ трансдермального введения и способ изготовления системы трансдермальной доставки
|
CN103751091B
(zh)
|
2008-02-28 |
2017-08-25 |
R·P·舍勒科技有限责任公司 |
使多晶型现象最小化的方法
|
US20110201804A1
(en)
|
2008-10-22 |
2011-08-18 |
Watson Pharma Private Limited |
Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
|
EP2385944A4
(en)
|
2009-01-09 |
2013-06-19 |
Harvard College |
FLUORINATED COMPOUNDS AND METHODS OF USE
|
WO2010148519A1
(en)
|
2009-06-25 |
2010-12-29 |
Queen's University At Kingston |
Methods and therapies for alleviating pain comprising an ultra low dose of an alpha 2 receptor antagonist
|
WO2011091050A1
(en)
|
2010-01-19 |
2011-07-28 |
Nektar Therapeutics |
Oligomer-tricyclic conjugates
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
EP2377522B1
(en)
|
2010-04-15 |
2013-01-16 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
|
EP2608829A4
(en)
|
2010-08-23 |
2015-11-18 |
Darren Rubin |
SYSTEMS AND METHODS FOR AEROSOL SUPPLY WITH AIRFLOW REGULATION
|
DE102010049706A1
(de)
|
2010-10-28 |
2012-05-03 |
Hexal Ag |
Herstellung orodispersibler Filme
|
US20130253449A1
(en)
|
2010-12-07 |
2013-09-26 |
Yutoku Pharmaceutical Industries Co., Ltd. |
Noradrenergic and specific serotonergic antidepressant-containing transdermal patch
|
EP2508174A1
(en)
|
2011-04-06 |
2012-10-10 |
Ljiljana Sovic Brkicic |
Pharmaceutical composition
|
GB2503187A
(en)
|
2011-09-15 |
2013-12-25 |
Univ Sussex |
Composition for use in the treatment of neurodevelopmental disorders
|
AU2012327191A1
(en)
*
|
2012-04-17 |
2013-10-31 |
Colorado State University Research Foundation |
Mirtazapine as an appetite stimulant for cats
|
US20150148758A1
(en)
*
|
2012-06-05 |
2015-05-28 |
Yutoku Pharmaceutical Industries Co., Ltd., |
Mirtazapine-containing transdermally-absorbable skin-adhesive preparation
|
EP2690102A1
(en)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bicyclic aza-amides for treatment of psychiatric disorders
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
US20140271727A1
(en)
|
2013-03-18 |
2014-09-18 |
National Yang-Ming University |
Method of using an antidepressant for increasing immunity of a subject and treating cancer
|
MX2015016675A
(es)
|
2013-06-04 |
2016-07-15 |
Vyome Biosciences Pvt Ltd |
Particulas recubiertas y composiciones que comprenden las mismas.
|
EP2856934A1
(en)
|
2013-10-04 |
2015-04-08 |
Les Laboratoires Servier |
Biomarkers for the prediction of long term remission in depression
|
GB201320675D0
(en)
|
2013-11-22 |
2014-01-08 |
Univ Nottingham |
Composition
|
KR102495941B1
(ko)
|
2013-12-03 |
2023-02-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
FR3015289B1
(fr)
|
2013-12-20 |
2017-01-13 |
Virbac |
Mirtazapine injectable
|